eCTD v4.0 Gap Analysis + Document Prep: How ECTD Pharma Helps You Avoid Costly Rejections
- Tom Marsden
- 6 days ago
- 2 min read

2026 Is Coming — And Most Teams Are Guessing
January 1, 2026: FDA requires eCTD v4.0. One bad PDF. One broken link. One missing bookmark. → Technical rejection. → Weeks of rework. → Delayed approval.
We’ve seen it:
80% of 2025 pilot issues were document-related. (FDA ESG Validation Trends, Q3 2025)
At ECTD Pharma, we’ve completed 12+ v4.0 gap analyses and document prep projects in 2025. Result: No client has had a technical rejection after our review.
Not magic. Just thorough, practical, human-reviewed work.
Our Service: Gap Analysis + Document Preparation
Fixed Price: $6,900 (covers one full module or up to 50 docs)
How It Works — Step by Step
1. Gap Analysis
We review every file against FDA v4.0 rules:
Broken links?
Missing study tags?
Non-compliant PDFs?
You get:
Clear report (PDF + Excel)
Prioritized fixes with out strict traffic light system
Risk level (low/medium/high)
2. Document Preparation
We fix what’s broken:
You get:
Clean, clickable PDFs
Validation-ready files
ESG test report (we run a mock)
Real Example: What We Fixed for a Client
Client: Small US biotech (IND resubmission) Problem:
38 PDFs
112 validation warnings
Broken hyperlinks, missing bookmarks
Our Fix (9 days):
Gap report → 112 issues mapped
Rebuilt all PDFs + hyperlinks
Ran mock v4.0 submission in ESG
Result:
ESG passed with 3 minor warnings (fixed same day). Client: “Saved us from a 3-week delay.”
7 Common Issues We Fix
Free Document Health Check (5 Minutes)
Ask yourself:
Are your PDFs PDF/A-3b?
Do all sections have bookmarks?
Are hyperlinks clickable in a new folder?
Is all text searchable?
Have you tested in ESG?
Not sure? We’ll check one PDF for free!
Why Work With ECTD Pharma?
No upsells. No surprises.




Comments